Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of AMG 181 in healthy subjects and subjects with Ulcerative Colitis has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AMG 181

Snippet

Sponsor: Amgen | Conditions: Ulcerative Colitis | Phase 1 | Status: TERMINATED